Pulmatrix, Inc. PULM
1.33 USD +0.03 (+2.31%)
Regular-session close
1.31 -0.02 -1.50%
After hours · Nov 16, 4:00 PM ET
1.25 Day range 1.39
1.06 52-week range 4.98
- YTD
- -40.36%
- 1 year
- -71.76%
News
globenewswire.com Eos SENOLYTIX's PTC-2105 Reduced Semaglutide-Associated Lean-Mass Loss in Aged Mice: Data to Be Presented at 19th Sarcopenia, Cachexia & Wasting Disorders International Conference Data to highlight PTC-2105's attenuation of terminal lean-mass decline and semaglutide-associated lean-mass loss in aged mice PTC-2105 is Eos's lead clinical candidate in development for elderly…benzinga.com Eos SENOLYTIX Presents New Preclinical Survival, Healthspan, Mechanism-Of-Action Data For Its PTC-2105 Candidate At 17th World Congress On Targeting Mitochondria 2026 Eos SENOLYTIX, Inc. ("Eos" or the "Company") a biotechnology company developing mitochondria-targeted geropeptides to improve healthspan, today presented new preclinical survival, healthspan and
